1.
Rev Infirm
; 71(277): 18-19, 2022 Jan.
Artigo
em Francês
| MEDLINE
| ID: mdl-35090622
RESUMO
The management of sickle cell disease, the leading genetic disease in France, has made immense progress in recent years thanks to the creation of reference centres and multidisciplinary expertise. Pediatric mortality has almost disappeared, but the disease is still burdened with significant morbidity. The challenge for the coming years is to reduce this morbidity in order to improve quality of life and prevent chronic diseases, which occur mainly in adults.